Correlation Between Kezar Life and Cns Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Cns Pharmaceuticals, you can compare the effects of market volatilities on Kezar Life and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Cns Pharmaceuticals.

Diversification Opportunities for Kezar Life and Cns Pharmaceuticals

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kezar and Cns is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Kezar Life i.e., Kezar Life and Cns Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kezar Life and Cns Pharmaceuticals

Considering the 90-day investment horizon Kezar Life Sciences is expected to generate 0.33 times more return on investment than Cns Pharmaceuticals. However, Kezar Life Sciences is 3.07 times less risky than Cns Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  7,030  in Kezar Life Sciences on August 28, 2024 and sell it today you would lose (6,283) from holding Kezar Life Sciences or give up 89.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kezar Life Sciences  vs.  Cns Pharmaceuticals

 Performance 
       Timeline  
Kezar Life Sciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.
Cns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Kezar Life and Cns Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kezar Life and Cns Pharmaceuticals

The main advantage of trading using opposite Kezar Life and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.
The idea behind Kezar Life Sciences and Cns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume